Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Receivables (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Receivables for 16 consecutive years, with $33.6 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 11.8% to $33.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.6 million through Dec 2025, up 11.8% year-over-year, with the annual reading at $33.6 million for FY2025, 11.8% up from the prior year.
  • Receivables for Q4 2025 was $33.6 million at Lemaitre Vascular, up from $32.4 million in the prior quarter.
  • The five-year high for Receivables was $36.5 million in Q2 2025, with the low at $19.5 million in Q3 2021.
  • Average Receivables over 5 years is $26.3 million, with a median of $25.2 million recorded in 2023.
  • The sharpest move saw Receivables fell 0.63% in 2021, then skyrocketed 35.12% in 2024.
  • Over 5 years, Receivables stood at $19.6 million in 2021, then rose by 12.27% to $22.0 million in 2022, then grew by 13.72% to $25.1 million in 2023, then increased by 19.94% to $30.1 million in 2024, then rose by 11.8% to $33.6 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $33.6 million, $32.4 million, and $36.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.